NEW

BAMF Health, United Imaging Celebrate Total-Body PET Clinic Focused on Theranostics

United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that the uEXPLORER, the company’s state-of-the-art digital two-meter total-body PET/CT, has arrived and is being installed at the Doug Meijer Medical Innovation Building...

New Report Provides Strategies for Managing Contrast Shortage

Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare Omnipaque™ iohexol iodinated contrast media (ICM) for radiologic examinations. A new Special Report published in the journal Radiology provides consensus...

Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022

Royal Philips is showcasing innovations at EuroPCR (May 17-20, Paris, France) that can enable interventionists to perform ultra-low contrast percutaneous coronary intervention (ULC-PCI) procedures with greater confidence and clarity. Philips’ ULC-PCI solutions...

Bruker Launches Novel 7 Tesla and 9.4 Tesla Preclinical MRI Magnets

At the ISMRM 2022 conference, Bruker announced the launch of innovative 7 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets for its market-leading preclinical magnetic resonance imaging (MRI) systems portfolio, according to a press release. Following the success...

Novel Cancer Therapy System Looks to Deliver Unparalleled Neurosurgical Care

ZAP-X

ZAP Surgical Systems Inc. has announced that Baptist Health South Florida, will acquire the ZAP-X Gyroscopic Radiosurgery platform for cranial stereotactic radiosurgery (SRS). The ZAP-X will be used by Miami Neuroscience Institute, in collaboration with Miami Cancer Institute, both part of Baptist Health South Florida, dedicated to offering the most innovative and advanced techniques to diagnose and treat brain disorders and tumors. Installation of the ZAP-X platform is expected to commence in late 2022.

As a non-invasive treatment for many primary and metastatic brain tumors, SRS is a well-established procedure that often provides equivalent to superior outcomes compared to surgery, yet requires no incision and is painless. SRS is typically delivered in one to five brief outpatient visits and patients often return to normal activity the same day as the procedure.

ZAP-X was designed to transform modern radiosurgery with a ground-breaking gyroscopic design which delivers hundreds of uniquely angled radiation beams precisely sculpted to the unique contours of targeted lesions. This novel capability aims to enhance patient outcomes by potentially improving the ability to avoid critical structures such as the brain stem, eyes, and optic nerves, while also lowering healthy brain tissue exposure to preserve patient cognitive function.

“When treating the brain, particularly with a procedure as complex as radiosurgery, the technology and precision must be exquisite,” states Michael McDermott, M.D., neurosurgeon and chief medical executive of Miami Neuroscience Institute. “ZAP-X is the latest advance in SRS, and the first new dedicated radiosurgery technology platform in over 30 years. This innovation enables our center to offer patients the highest level of care.”

ZAP-X is recognized for being the first and only vault-free SRS delivery system, thereby eliminating the need for providers to build costly shielded radiation treatment rooms. This unique feature also allows clinicians to remain immediately adjacent to the patient during treatment, in contrast to the long-standing practice of patients being sequestered in a shielded delivery suite during therapy.

Utilizing a modern linear accelerator to produce radiation, ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, consequently eliminating the significant efforts and costs to host, secure and regularly replace radioactive isotopes.

“Miami Cancer Institute is in the unique position of having access to virtually every radiation delivery technology available,” added Dr. Minesh Mehta, M.D., deputy director and chief of radiation oncology at Miami Cancer Institute. “This allows our team to align each patient with a tailored therapy and technology for highly individualized indications and needs. We look forward to ZAP-X further complementing our portfolio of therapeutic solutions.”

To facilitate rapid installation, ZAP-X will initially be located within a temporary facility and will soon migrate to the new Miami Neuroscience Institute building at Baptist Health South Florida’s Dadeland campus.

For more information, visit www.zapsurgical.com.

 

Previous

Next

Submit a Comment

Your email address will not be published.